RESUMEN
The pathogenetic mechanisms of acute alcoholic intoxications are examined and is based the expediency of the search for the amethystic agents, which influence neurotransmitter systems. Promising should be considered the agents, which modulate GABA-systems (partial reverse agonists of benzodiazepine receptors), glutamate (antagonists of metabotropic receptors mGluR2/3), opioid neuropeptides (antagonists of opioid receptors), acetylcholine (reversible inhibitors of acetylcholinesterase and M-cholinoagonists), adenosine (selective antagonists of A(2A)-receptors). The amethystic effect manifest also the substances, which modify the second messengers systems (calcium, nitrergic and cascade of arachidonic acid). The most of the means examined possesses the moderate amethystic potential, and effectiveness is manifested predominantly during the preventive application.
Asunto(s)
Intoxicación Alcohólica/prevención & control , Encéfalo/efectos de los fármacos , Etanol/farmacocinética , Intoxicación Alcohólica/metabolismo , Animales , Encéfalo/metabolismo , Etanol/administración & dosificación , Etanol/toxicidad , Humanos , Neurotransmisores/administración & dosificación , Neurotransmisores/química , Neurotransmisores/uso terapéutico , Receptores de GABA/metabolismo , Receptores de N-Metil-D-Aspartato/metabolismo , Receptores Opioides/metabolismo , Receptores de Serotonina/metabolismoRESUMEN
In work the review of some clinik-morphological and pharmacological researches devoted to a temporal epilepsy and its experimental models is resulted. On the basis of the analysis of existing problems in working out antiepileptic drugs and in studying of mechanisms epilepsy necessity of development of new chronic experimental models of a temporal epilepsy is proved. The basic criteria of experimental model of a temporal epilepsy are generalised. It is shown that parametres of acute toxicity and the remote consequences of an intoxication convulsive agents from group GABA-receptor's chloride channel blockers correspond to the basic criteria a post-epistatus of model of a temporal epilepsy. The conclusion is presented on use possibility GABA-receptor's chloride channel blockers in quality agents for modelling of a temporal epilepsy.
Asunto(s)
Anticonvulsivantes/administración & dosificación , Canales de Cloruro/antagonistas & inhibidores , Modelos Animales de Enfermedad , Epilepsia del Lóbulo Temporal/inducido químicamente , Epilepsia del Lóbulo Temporal/fisiopatología , Antagonistas del GABA/administración & dosificación , Animales , Anticonvulsivantes/aislamiento & purificación , Hidrocarburos Aromáticos con Puentes/administración & dosificación , Descubrimiento de Drogas , Humanos , Excitación Neurológica/efectos de los fármacos , Norbornanos/administración & dosificaciónRESUMEN
The involvement of brain neurotrophic factors (BNF) in the development and maintenance of the syndrome of psychic dependence on psychoactive substances is discussed. The implication of BNF in the pathogenesis of psychic dependence syndrome is supported by changes of the addictive power of psychostimulants, ethanol and morphine in conditions of metabolism modulation of these peptides as well as in rodents with defects in neurotrophin genes. Glial cell line derived BNF and tumor necrosis factor-alpha reduce the addictive potential of cocaine, methamphetamine, morphine and ethanol. Brain-derived neurotrophic factor, on the contrary, increases the addictive activity of cocaine suppressing the development of the syndrome of psychic dependence on ethanol. Thus, the BNF must be considered as an important group of neuroactive peptides implicated in the pathogenesis of chemical dependences.
Asunto(s)
Alcoholismo/metabolismo , Encéfalo/metabolismo , Trastornos Relacionados con Cocaína/metabolismo , Dependencia de Morfina/metabolismo , Factores de Crecimiento Nervioso/metabolismo , Alcoholismo/genética , Animales , Cocaína/envenenamiento , Trastornos Relacionados con Cocaína/genética , Etanol/envenenamiento , Humanos , Metanfetamina/envenenamiento , Ratones , Morfina/envenenamiento , Dependencia de Morfina/genética , Factores de Crecimiento Nervioso/genéticaRESUMEN
Naltrexone and naloxone, being competitive antagonists of opioid receptors, have found therapeutic applications in medicine. The experiments with mutant receptors showed that many amino acid residues within transmembrane domains play an important role in binding these drugs. Using the site-directed mutagenesis technique, it was established that even single mutations (replacing single amino acid residues) can significantly modify the affinity of antagonists to receptors, sometimes even imparting agonist-like properties to the compounds studied. Chronic administration of naltrexone and naloxone leads to an increase in the density of opioid receptors and in the sensitivity to agonists. This hypersensitivity and overdose risk in heroin abusers after chromic naltrexone treatment are discussed.
Asunto(s)
Naloxona/farmacología , Naltrexona/farmacología , Antagonistas de Narcóticos/farmacología , Animales , Humanos , Ligandos , Mutación , Naloxona/metabolismo , Naltrexona/metabolismo , Antagonistas de Narcóticos/metabolismo , Receptores Opioides/genética , Receptores Opioides/metabolismoRESUMEN
Ultra rapid opioid detoxification (UROD) is a new technique with the use of mu-opioid receptor antagonists to precipitate withdrawal. The scientific literature on UROD techniques in opiate addicts are reviewed, but little has been published on its neurochemical aspects. It is discussed that exposure to naloxone ore naltrexone during UROD is associated with development of increasing in opioidergic neurotransmission. On the other hand, ultra rapid opioid detoxification can be accompanied by normalization of joined brain neurotransmitter systems: noradrenergic, serotoninergic, GABAergic, cholinergic and glutamatergic neurotransmission systems. The neurochemical aspects of the new method detoxification are discussed.
Asunto(s)
Trastornos Relacionados con Opioides/metabolismo , Síndrome de Abstinencia a Sustancias/prevención & control , Transmisión Sináptica/efectos de los fármacos , Animales , Humanos , Naloxona/uso terapéutico , Naltrexona/uso terapéutico , Antagonistas de Narcóticos/uso terapéutico , Neurotransmisores/metabolismo , Neurotransmisores/fisiología , Trastornos Relacionados con Opioides/terapia , Receptores Opioides/efectos de los fármacosRESUMEN
Gamma aminobutyric acid (GABA) is one of the main inhibitory neurotransmitters in the mammalian brain. Its effects are realized via GABA(A), GABA(B), and GABA(C) receptors. GABA(A) is the most abundant type of GABA receptors. It consists of six classes of subunits, alpha, beta, gamma, delta, epsilon, and chi. Acute and chronic exposures to ethanol are accompanied by changes in structure and function of GABA(A) receptors. These changes may be a basis for altered behavior seen in alcoholism.
Asunto(s)
Etanol/farmacología , Receptores de GABA/metabolismo , Alcoholismo/metabolismo , Animales , Etanol/administración & dosificación , Humanos , Subunidades de Proteína , Receptores de GABA/química , Ácido gamma-Aminobutírico/farmacologíaAsunto(s)
Agonistas alfa-Adrenérgicos/farmacología , Trastornos Relacionados con Opioides/tratamiento farmacológico , Agonistas alfa-Adrenérgicos/uso terapéutico , Animales , Encéfalo/metabolismo , Encéfalo/patología , Clonidina/farmacología , Clonidina/uso terapéutico , Humanos , Síndrome de Abstinencia a Sustancias/metabolismo , Síndrome de Abstinencia a Sustancias/patologíaRESUMEN
The properties of acamprosate (calcium acetylhomotaurate), a new remedy for the treatment of alcoholism, are reviewed. The efficacy of this drug has been verified by numerous clinical tests in West Europe. The pharmacological activity of acamprosate is related to the drug action upon central neuromediator systems. No side or addiction effects of the drug were reported. Data on the clinical and pharmacological characteristics of acamprosate are summarized.
Asunto(s)
Disuasivos de Alcohol/uso terapéutico , Alcoholismo/tratamiento farmacológico , Taurina/análogos & derivados , Acamprosato , Disuasivos de Alcohol/farmacología , Ensayos Clínicos como Asunto , Humanos , Taurina/farmacología , Taurina/uso terapéuticoRESUMEN
The structural-functional foundations of the heterogeneity of GABA(A)-receptors are discussed. The heterogeneity of the receptors was revealed by clone-formation methods. The existence of 5 classes of subunits (alpha, beta, gamma, delta, rho) was proved, each of them possessing isoforms (alpha 1-6, beta 1-4, gamma 1-4, delta, rho 1-2). Studies with expression of receptors showed the efficacy of neuroactive drugs of various groups (agonists, antagonists, reversible agonists of benzodiazepine receptors, barbiturates) to be dependent on the subunit composition of the complexes. Because of this, study of the properties of various recombinant receptors is very important for the advancement of neurobiology, neuropathology, neurochemistry, toxicology, and pharmacology.
Asunto(s)
Receptores de GABA-A/efectos de los fármacos , Animales , Barbitúricos/farmacología , Benzodiazepinas/farmacología , Ligandos , Receptores de GABA-A/clasificación , Receptores de GABA-A/fisiologíaRESUMEN
It is generally accepted that gamma-aminobutyric acid (GABA) is the most important inhibitory transmitter. It interacts with specific receptors. In the central nervous system of the vertebrates there are three types of GABA receptors: GABAA, GABAB, and GABAC receptors. Channel gating at GABAA receptors allosterically is modulated by a wide of neuroactive compounds, including benzodiazepine ligands. The structural and functional bases for the heterogeneity of benzodiazepine receptors are discussed. Investigations of the functional properties of GABAA and benzodiazepine receptors may contribute to progress in neurobiology, neuropathology, neurochemistry, toxicology, and pharmacology.
Asunto(s)
Sistema Nervioso Central/metabolismo , Receptores de GABA-A/química , Secuencia de Aminoácidos , Animales , Humanos , Activación del Canal Iónico , Datos de Secuencia Molecular , Receptores de GABA-A/metabolismo , Transmisión Sináptica/fisiologíaRESUMEN
It is generally accepted that gamma-aminobutyric acid (GABA) is one of the main inhibitory transmitter in the mammalian brain. There are three types of GABA receptors in the vertebrata central nervous system: the GABAA, GABAB and GABAC receptors. The GABAA receptor is a GABA-gated Cl- channel and is the tetramer ore the pentamer made of some classes of subunit (alpha, beta, gamma, delta). GABAB receptors are not affiliated with Cl(-) ionophore. GABAB receptors appear to be coupled to Ca2+ and K+ channels of presynaptic membranes. It seems they regulate the release of neurotransmitters release. The structural and functional properties of GABA receptors are discussed.
Asunto(s)
Receptores de GABA/fisiología , Animales , Agonistas del GABA/farmacología , Antagonistas del GABA/farmacología , Ligandos , Receptores de GABA/clasificación , Receptores de GABA/efectos de los fármacos , Relación Estructura-Actividad , Ácido gamma-Aminobutírico/fisiologíaRESUMEN
A growing bulk of experimental data indicates that change of certain neurotransmitter receptors and voltage-dependent ion cannels are characteristic manifestations accompanying ethanol consumption. A likely target for ethanol effects is the glutamate receptors. Glutamate is one of major excitatory neurotransmitter in the mammalian brain. While the acute application of ethanol inhibits glutamate-induced cationic currents, chronic treatment with ethanol leads to an up-regulation of glutamate receptors.
Asunto(s)
Alcoholismo/fisiopatología , Etanol/toxicidad , Receptores de Glutamato/fisiología , Animales , Humanos , Técnicas In Vitro , Receptores de Glutamato/efectos de los fármacosAsunto(s)
Convulsivantes/toxicidad , Excitación Neurológica , Norbornanos/toxicidad , Convulsiones/fisiopatología , Animales , Bicuculina/toxicidad , Canales de Cloruro/antagonistas & inhibidores , Antagonistas de Dopamina/farmacología , Agonistas del GABA/farmacología , Antagonistas del GABA/toxicidad , Dosificación Letal Mediana , Masculino , Ratones , Agonistas Muscarínicos/farmacología , Picrotoxina/toxicidad , Receptores de GABA-A/efectos de los fármacos , Convulsiones/inducido químicamenteAsunto(s)
Convulsivantes/toxicidad , Excitación Neurológica/efectos de los fármacos , Norbornanos/toxicidad , Ácido 3-Mercaptopropiónico/metabolismo , Ácido 3-Mercaptopropiónico/toxicidad , Animales , Canales de Cloruro/antagonistas & inhibidores , Convulsivantes/metabolismo , Antagonistas de Receptores de GABA-A , Dosificación Letal Mediana , Masculino , Ratones , Norbornanos/metabolismo , Picrotoxina/metabolismo , Picrotoxina/toxicidad , Membranas Sinápticas/efectos de los fármacos , Membranas Sinápticas/metabolismoRESUMEN
Perfluorane (a phenobarbital-type inducer of the microsomal enzyme system) raised the resistance of mice to the toxic effect of picrotoxin and bicucullin in 7 days after injection. The antidote effect of diazepam and phenobarbital increased under such conditions. In experiments in vitro a modulatory effect of perftorane on the central muscarine and benzodiazepine receptors was demonstrated.